PPT-Dual Anti-Platelet Therapy After TAVR?

By Cole Smith PharmD Candidate 2021 University of Findlay Preceptor Katherine Crawford PharmD BCCP POPular TAVI Cohort B Trial Review Background TAVITAVR Transcatheter aortic valve implantreplacement Utilized for patients who have aortic stenosis to help when their valve is not opening correctly . Thrombocytes. Platelets (Thrombocytes). 2- 4 micromillimeters in diameter. 250,000 – 400,000 per microliter . (too few thrombocytopenia – too many thrombocytosis). Lifespan on average 6 – 10 days. Thrombocytes. Platelets (Thrombocytes). 2- 4 micromillimeters in diameter. 250,000 – 400,000 per microliter . (too few thrombocytopenia – too many thrombocytosis). Lifespan on average 6 – 10 days. Autoimmune (ITP). Childhood. Adult. Drug-induced. Heparin. Quinine, others. Immune complex (infection, etc). Alloimmune. Post-transfusion purpura. Neonatal purpura. ITP. Childhood ITP (most < 10 . Program Goals. Thromboembolic Risk Associated With TAVR. Timing of Stroke and Bleeding Post TAVR. Stroke After TAVR -- Pathophysiology. TAVR and AF Background. Leaflet Thrombosis in Bioprosthetic Aortic Valves: Clinical Outcomes . Overview of Anticoagulation in . Interventional Cardiology. Rivaroxaban in Patients With Recent ACS:. ATLAS ACS 2-TIMI 51. Apixaban After ACS: APPRAISE-2. How Do You Treat Complex Patients?. ACC/AHA Guidelines. Stanton J Rowe. CEO. NXT Biomedical. I, Stanton Rowe, DO have a financial interest/arrangement . or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.. thrombocytopenia. ) constitutes an important cause of generalized bleeding.. A count less than 100,000 platelets/. μL. is generally considered to constitute thrombocytopenia. . Platelet counts in the range of 20,000 to 50,000 platelets/. ”. Muhammad Raza, MD, FACC, FSCAI, RPVI.. Interventional cardiologist. Director, Cardiac Cath Lab, . Crozer. Chester Medical Center,. Upland, PA. . Disclosure. Consultant and Proctor – Medtronic. Michael Mack, MD. Baylor Scott & White Health. Dallas, TX. How Have Most Operators and Centers Been Trained in Structural Heart?. 3. Do We Need Formal “Structured” Training in Structural Heart?. Mohammad Faranoush,MD . Professor of pediatric Hematology Oncology. Iran University of Medical Sciences. Rasool Akram Medical Complex. Disclosures. No conflict of interest. Introduction. Platelets play a crucial role in hemostasis.. Shilpa Shelton, MBA. Program Director, . Bluhm. Cardiovascular Institute. Northwestern Medicine. “Back to the Basics: Coding, Documentation, Coverage”. Disclaimer. The information provided is the experience of the . Paige Lipski. Overview of coagulation. In health components of coagulation all present in circulation and only become activated when injury occurs. Injury results in:. -vasoconstriction to reduce blood loss and assist platelet adhesion. At the end of this unit of study, the student should be able to:. Describe the normal morphology and number of platelets on a peripheral blood smear and state the normal life span and concentration of platelets in the blood.. A Heart Team Perspective. Interventional cardiology: . Megan Coylewright, MD MPH FSCAI. Dartmouth-Hitchcock Heart and Vascular Center. Cardiac surgery: . Melissa Levack, MD. Vanderbilt University Medical Center.